Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Related Articles by Review for PubMed (Select 23593992)

1.

Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?

Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A.

CNS Neurosci Ther. 2013 Aug;19(8):549-55. doi: 10.1111/cns.12095. Epub 2013 Apr 18. Review.

PMID:
23593992
3.

Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias.

Molinuevo JL, Lladó A, Rami L.

Am J Alzheimers Dis Other Demen. 2005 Mar-Apr;20(2):77-85. Review.

PMID:
15844753
5.

Alzheimer's disease and the glutamate NMDA receptor.

Doraiswamy PM.

Psychopharmacol Bull. 2003 Spring;37(2):41-9. Review.

PMID:
14566213
6.
7.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Grossberg GT, Edwards KR, Zhao Q.

J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. Review.

PMID:
16809811
8.

NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.

Farlow MR.

Geriatrics. 2004 Jun;59(6):22-7. Review.

PMID:
15224791
9.

Neuropathologic changes in Alzheimer's disease: potential targets for treatment.

Wenk GL.

J Clin Psychiatry. 2006;67 Suppl 3:3-7; quiz 23. Review.

PMID:
16649845
10.

Disease-modifying drugs in Alzheimer's disease.

Ghezzi L, Scarpini E, Galimberti D.

Drug Des Devel Ther. 2013 Dec 6;7:1471-8. doi: 10.2147/DDDT.S41431. Review.

11.

Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.

Tariot PN.

J Clin Psychiatry. 2006;67 Suppl 3:15-22; quiz 23. Review.

PMID:
16649847
12.

[Efficacy of memantine in the treatment of Alzheimer's disease].

Molinuevo Guix JL, Lladó Plarrumaní A.

Neurologia. 2005 Dec;20(10):686-91. Review. Spanish.

PMID:
16317590
13.
14.

Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Danysz W, Parsons CG.

Br J Pharmacol. 2012 Sep;167(2):324-52. doi: 10.1111/j.1476-5381.2012.02057.x. Review.

15.

The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.

Rogawski MA, Wenk GL.

CNS Drug Rev. 2003 Fall;9(3):275-308. Review.

PMID:
14530799
16.

[Treatment of Alzheimer's disease].

Bombois S, Lebert F, Vellas B, Pasquier F.

Rev Prat. 2005 Nov 15;55(17):1913-9. Review. French.

PMID:
16396232
17.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
18.

Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.

Sonkusare SK, Kaul CL, Ramarao P.

Pharmacol Res. 2005 Jan;51(1):1-17. Review.

PMID:
15519530
19.

The role of the N-methyl-D-aspartate receptor in Alzheimer's disease: therapeutic potential.

Doraiswamy PM.

Curr Neurol Neurosci Rep. 2003 Sep;3(5):373-8. Review.

PMID:
12914679
20.

An update on drug treatment options of Alzheimer's disease.

Allgaier M, Allgaier C.

Front Biosci (Landmark Ed). 2014 Jun 1;19:1345-54. Review.

PMID:
24896354
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk